small business Grant Search

The following government grants in the FederalGrants.com database contain the term small business in the listing.

Grants are sorted newest to oldest. Select a grant title to view the complete details, including information on who to contact and how to apply.

Grant Title	CFDA	Funding Number
Global Brain and Nervous System Disorders Research Across the Lifespan (R21 Clinical Trial Optional)	93.113, 93.173, 93.242, 93.853, 93.865, 93.866, 93.867, 93.989	PAR-21-319
The Human BioMolecular Atlas Program (HuBMAP) Demonstration Project (U01 Clinical Trial Not Allowed)	93.310	RFA-RM-21-027
Small Vessel VCID Biomarkers Validation Consortium Coordinating Center (U24 Clinical Trial Not Allowed)	93.853	RFA-NS-22-017
Small Business Innovation Research Program Phase I	10.212	USDA-NIFA-SBIR-008541
NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 Clinical Trial Required)	93.398	PAR-21-299
Administrative Supplements to Promote Diversity in Small Businesses-SBIR/STTR (Admin Supp Clinical Trial Not Allowed)	93.070, 93.113, 93.121, 93.136, 93.172, 93.173, 93.213, 93.233, 93.242, 93.262, 93.273, 93.279, 93.286, 93.307, 93.350, 93.351, 93.361, 93.393, 93.394, 93.395, 93.396, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.853, 93.855, 93.859, 93.865, 93	PA-21-345
Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Not Allowed)	93.853	PAR-21-328
NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 Independent Clinical Trial Not Allowed)	93.398	PAR-21-300
AIDS-Science Track Award for Research Transition (R03 Clinical Trial Optional)	93.279	PAS-21-270
NCI Transition Career Development Award to Promote Diversity (K22 Independent Clinical Trial Not Allowed)	93.398	PAR-21-301
An Intergenerational Precision Medicine Research Program for the Study of Factor VIII Immunogenicity in Severe Hemophilia A: Hemophilia A Analytical Cohort Research Program (UG3/UH3 Clinical Trial Not Allowed)	93.839	RFA-HL-22-004
OSBDC Funding Opportunity for the State of Louisiana	59.037	OSBDC-2022-03
NCI Transition Career Development Award to Promote Diversity (K22 Clinical Trial Required)	93.398	PAR-21-302
Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Required)	93.853	PAR-21-327
Technical Assistance to the Survivors of Torture Program	93.604	HHS-2022-ACF-ORR-ZT-0050
Direct Services for Survivors of Torture	93.604	HHS-2022-ACF-ORR-ZT-0051
Lighthouse: Services, Outreach, and Awareness for Labor Trafficking (Lighthouse) Demonstration Program	93.598	HHS-2022-ACF-IOAS-OTIP-ZV-0059
Detecting Cognitive Impairment, Including Dementia, in Primary Care and Other Everyday Clinical Settings for the General Public and Health Equity, Pragmatic Clinical Trials (U01 Clinical Trial Required)	93.853, 93.866	RFA-NS-22-009
Career Pathways Secondary Data Analysis Grants	93.595	HHS-2022-ACF-OPRE-PE-0080
Rigorously Evaluating Programs and Policies to Prevent Child Sexual Abuse (CSA)	93.136	RFA-CE-22-003
Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed)	93.393	PAR-21-330
Research Grants for Preventing Violence and Violence Related Injury (R01)	93.136	RFA-CE-22-005
SBDC in the Commonwealth of the Northern Mariana Islands (CNMI)	59.037	OSBDC-2022-04
Pharmacokinetics (PK) and Pharmacodynamics (PD) of THC in Cannabis and Cannabis Products (R21 - Clinical Trial Optional)	93.279	RFA-DA-22-039
Pharmacokinetics (PK) and Pharmacodynamics (PD) of THC in Cannabis and Cannabis Products (R01 - Clinical Trial Optional)	93.279	RFA-DA-22-028
High Priority HIV and Substance Use Research (R01 Clinical Trial Optional)	93.279	RFA-DA-22-040
Grants to Support New Investigators in Conducting Research Related to Understanding Polydrug Use Risk and Protective Factors	93.136	RFA-CE-22-001
Research Grants to Prevent Firearm-Related Violence and Injuries (R01)	93.136	RFA-CE-22-004
Silvio O. Conte Digestive Diseases Research Core Centers (P30 Clinical Trial Optional)	93.847	RFA-DK-21-026
Victims of Human Trafficking Services and Outreach Program - Pacific Region Demonstration Program (VHT-SO Pacific Program)	93.598	HHS-2022-ACF-IOAS-OTIP-ZV-0038
I-FASD: Understanding Clinical Data and Pathways to Inform Surveillance of Children with Fetal Alcohol Spectrum Disorders	93.073	CDC-RFA-DD22-2202
Secondary Analyses of Head Start and Early Head Start Data	93.600	HHS-2022-ACF-OPRE-YR-0058
Secondary Analyses of Child Care and Early Education Data	93.575	HHS-2022-ACF-OPRE-YE-0057
Mechanisms that Impact Cancer Risk after Bariatric Surgery (R01 Clinical Trial Optional)	93.393, 93.396, 93.399	PAR-21-331
Mechanisms that Impact Cancer Risk after Bariatric Surgery (R21 Clinical Trial Not Allowed)	93.393, 93.396, 93.399	PAR-21-332
Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional)	93.279	PAR-22-027
Basic Research in Cancer Health Disparities (R03 Clinical Trial Not Allowed)	93.393	PAR-21-324
NIDDK Inflammatory Bowel Disease Genetics Consortium (IBDGC) Genetic Research Centers (GRCs) (U01 Clinical Trial Optional)	93.847	RFA-DK-21-022
Partnership for Enhanced Efforts To Strengthen The Nation's Healthcare And Public Health Preparedness, Response, And Recovery To Disasters And Other Emergencies	93.078	EP-HIT-21-004
Collaborative Partnership between Research Centers in Minority Institutions (RCMI) and Alcohol Research Centers (U54 Clinical Trial Optional)	93.273	RFA-AA-21-015
Search Results 3001-3040 of 21019 [Prev] 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 [Next]